Indaptus Therapeutics, Inc. (INDP) vs Monopar Therapeutics Inc. (MNPR)
Indaptus Therapeutics, Inc. and Monopar Therapeutics Inc. are both Biotechnology companies. Indaptus Therapeutics, Inc. and Monopar Therapeutics Inc. are of similar size ($606.8M and $602.8M). Across the 8 metrics below, Monopar Therapeutics Inc. leads on 7 and Indaptus Therapeutics, Inc. on 1.
Valuation
Profitability
| Metric | INDP | MNPR | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (318.04%) | (19.50%) | (57.72%) |
| Return on assets | (163.84%) | (18.90%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack